VSee Health, Inc.
VSEE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.13 | 0.75 | 4.32 |
| FCF Yield | -42.08% | -0.37% | -0.84% | -0.35% |
| EV / EBITDA | -6.88 | -97.30 | 0.00 | 0.00 |
| Quality | ||||
| ROIC | -625.15% | 49.88% | -186.37% | 0.15% |
| Gross Margin | 68.87% | 66.47% | 75.81% | 80.74% |
| Cash Conversion Ratio | 0.10 | 0.17 | 0.45 | 2.14 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.78% | -7.72% | -2.14% | 1,943,082.06% |
| Free Cash Flow Growth | -817.65% | 56.16% | -142.12% | -176.05% |
| Safety | ||||
| Net Debt / EBITDA | -2.75 | -0.24 | 0.00 | 0.00 |
| Interest Coverage | -293.91 | -0.86 | -13.34 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -403.25 | 4.44 | -140.45 | -38.05 |